Ventricular Assist Devices Market Expected to Reach $2,880.66 million by 2031

ventricular assist devices market size was valued at $1,338.53 million in 2021, and is projected to reach $2,880.66 million by 2031, growing at a CAGR of 7.9% from 2022 to 2031. Ventricular assist devices market analysis provided from 2021 to 2031 to identify the prevailing market opportunities. Major factors that drive the growth of ventricular assist devices include the increase in prevalence of heart failure, technological advancements in the field of medical devices, and surge in patient awareness about ventricular assist devices.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Bivacor Inc., LivaNova PLC, Corewave SA, SynCardia Systems, LLC, Carmat SA, Berlin Heart GmbH, AdjuCor GmbH, Jarvik Heart, Inc., Calon Cardio-Technology Ltd, NuPulseCV, Inc., Abbott Laboratories, Evaheart, Inc., Abiomed, Inc., Windmill Cardiovascular Systems, CH Biomedical, Inc., Fineheart

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/2024

On the basis of application, the ventricular assist devices industry is categorized bridge-to-transplant (BTT), destination therapy, bridge-to-recovery (BTR), and bridge to candidacy therapy. The bridge-to-transplant (BTT) segment exhibited the highest growth in 2021, owing to the rise in awareness among people regarding bridge-to-transplant therapy, which has significantly increased the success rate of transplant surgeries. On the other hand, destination therapy segment is anticipated to grow at a high rate during the forecast period as VADs have become a prominent solution for people with heart failure and for those who are ineligible for heart transplantation.

On the basis of design, the market is segmented into transcutaneous ventricular assist devices and implantable ventricular assist devices. The implantable ventricular assist devices segment held the largest share of revenue in 2021 and is anticipated to grow at a fastest CAGR rate during the forecast period. This growth is attributed to the technological advancements in the field of VADs and rise in research activities to develop efficient and high quality implantable ventricular assist devices.

On the basis of age, the market is bifurcated into adults and pediatric. The adults segment was the largest segment in terms of revenue in 2021, owing to the rise in heart failure in adults due to lifestyle changes such as smoking. On the other hand, pediatrics segment is anticipated to grow at a fastest rate during the forecast period, owing to technological advancements in the field of VADs and development of pediatric VADs that are highly efficient in treating heart failure in pediatric patients.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/2024

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

By product, the left ventricular assist devices (LVADs) segment was the highest contributor to the market in 2021 and is anticipated to grow at a fastest rate during the ventricular assist devices market forecast period.

By application, the bridge-to-transplant (BTT) segment dominated the market in 2021 in terms of revenue and destination therapy segment is anticipated to grow at a fastest rate during the forecast period.

By design, the implantable ventricular assist devices segment dominated the global market in 2021 and is anticipated to grow at a high rate during the forecast period.

By age, the adults segment dominated the market in 2021. However, pediatrics segment is anticipated to grow at the highest CAGR during the forecast period.

Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.